체외막산소공급장치(ECMO) 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Extracorporeal Membrane Oxygenation Machine Market size is expected to reach USD 653.74 Million in 2034 from USD 383.02 Million (2025) growing at a CAGR of 6.12% during 2026-2034.

The global extracorporeal membrane oxygenation (ECMO) machine market is growing steadily due to the increasing demand for advanced life-support systems in critical care settings. ECMO machines provide temporary support for patients with severe heart or lung failure by oxygenating the blood outside the body. These devices are commonly used in intensive care units and during complex cardiac or respiratory treatments.

A key driver of this market is the rising incidence of severe respiratory and cardiovascular diseases. The increased use of ECMO during critical conditions such as acute respiratory distress syndrome has significantly expanded its adoption in hospitals. Additionally, advancements in medical technology and improved patient monitoring systems are enhancing the safety and effectiveness of ECMO treatments.

Looking ahead, the ECMO machine market is expected to grow as healthcare systems invest in advanced critical care technologies. Continuous research and development in life-support equipment will improve device performance and patient outcomes. Expanding healthcare infrastructure and increased training for healthcare professionals are also expected to support market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Component

• Pumps
• Oxygenator
• Controllers
• Cannula
• Accessories

By Modality

• Veno-Arterial
• Veno-Venous
• Arterio-Venous

By Application

• Respiratory
• Cardiac
• ECPR

By Patient Type

• Neonates
• Pediatric
• Adult

COMPANIES PROFILED

• Medtronic Plc, Maquet Holding, Microport Scientific Corporation, Terumo Cardiovascular System Corporation, Medos Medizintechnik, Nipro Medical Corporation, LivaNova PLC, CytoSorbents Corporation, Eurosets SRL
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET: BY COMPONENT 2022-2034 (USD MN and K Units)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 4.3. Oxygenator Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 4.4. Controllers Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 4.5. Cannula Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 4.6. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET: BY MODALITY 2022-2034 (USD MN and K Units)

• 5.1. Market Analysis, Insights and Forecast Modality
• 5.2. Veno-Arterial Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 5.3. Veno-Venous Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 5.4. Arterio-Venous Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET: BY APPLICATION 2022-2034 (USD MN and K Units)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Respiratory Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 6.3. Cardiac Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 6.4. ECPR Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET: BY PATIENT TYPE 2022-2034 (USD MN and K Units)

• 7.1. Market Analysis, Insights and Forecast Patient Type
• 7.2. Neonates Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 7.3. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
• 7.4. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET: BY REGION 2022-2034 (USD MN and K Units)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 8.2.1 By Component
  • 8.2.2 By Modality
  • 8.2.3 By Application
  • 8.2.4 By Patient Type
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 8.3.1 By Component
  • 8.3.2 By Modality
  • 8.3.3 By Application
  • 8.3.4 By Patient Type
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 8.4.1 By Component
  • 8.4.2 By Modality
  • 8.4.3 By Application
  • 8.4.4 By Patient Type
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 8.5.1 By Component
  • 8.5.2 By Modality
  • 8.5.3 By Application
  • 8.5.4 By Patient Type
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
  • 8.6.1 By Component
  • 8.6.2 By Modality
  • 8.6.3 By Application
  • 8.6.4 By Patient Type
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Medtronic Plc
  • 10.2.2 Maquet Holding
  • 10.2.3 Microport Scientific Corporation
  • 10.2.4 Terumo Cardiovascular System Corporation
  • 10.2.5 Medos Medizintechnik
  • 10.2.6 Nipro Medical Corporation
  • 10.2.7 LivaNova PLC
  • 10.2.8 CytoSorbents Corporation
  • 10.2.9 Eurosets S.R.L